Nasopharyngeal Carcinoma Screening in Zhongshan City

NCT02501993 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25000

Last updated 2023-07-13

No results posted yet for this study

Summary

The primary objective is to determine the early diagnosis rate and mortality rate of the Nasopharyngeal Carcinoma (NPC) in the study population.

The secondary objective is to determine the incidence of NPC in the study population.

Conditions

  • Nasopharyngeal Carcinoma

Sponsors & Collaborators

  • Zhongshan People's Hospital, Guangdong, China

    lead OTHER

Principal Investigators

  • Mingfang Ji, MD · Zhongshan People's Hospital, Guangdong, China

Eligibility

Min Age
30 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2019-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02501993 on ClinicalTrials.gov